Video Experimental Relacionado
Updated: Sep 10, 2025
09:08
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.8K
La señalización de muescas en enfermedades metabólicas: un regulador clave y un objetivo potencial
Zhaoqing Xi1, Junxia Zhang2, Mingwei Bao1
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan, 430060, China; Hubei Key Laboratory of Cardiology, Wuhan, 430060, China.
Biochemical and biophysical research communications
|August 20, 2025
Resumen
La vía de señalización de Notch juega un papel clave en enfermedades metabólicas como la obesidad y la diabetes. La inhibición de esta vía ofrece nuevas terapias potenciales para estos crecientes problemas de salud.
Área de la Ciencia:
- Bioquímica y Biología Molecular
- Señalización celular
- Investigación de las enfermedades metabólicas
Sus antecedentes:
- Las enfermedades metabólicas, incluida la obesidad y la diabetes, están aumentando a nivel mundial, lo que requiere investigación sobre sus causas y tratamientos.
- La vía de señalización de Notch es crucial para la comunicación y el desarrollo celular, pero su activación aberrante está relacionada con la disfunción metabólica.
- La evidencia emergente implica la señalización de Notch en el deterioro de la homeostasis energética y la progresión de la obesidad, NAFLD, NASH, diabetes y enfermedades cardiovasculares.
Objetivo del estudio:
- Revisar los mecanismos por los que la vía de señalización de Notch contribuye a las enfermedades metabólicas.
- Para explorar el papel de la señalización de Notch en la obesidad, NAFLD, NASH, diabetes y aterosclerosis.
- Identificar posibles objetivos terapéuticos mediante el examen de las estrategias de inhibición de Notch.
Principales métodos:
- Revisión exhaustiva de la literatura de estudios sobre la señalización de Notch y las enfermedades metabólicas.
- Análisis de la investigación que detalla las funciones fisiopatológicas de Notch en los trastornos metabólicos.
- Examen de los datos preclínicos y clínicos sobre las terapias de inhibición de Notch.
Principales resultados:
- La señalización aberrante de Notch deteriora la homeostasis energética, promoviendo trastornos metabólicos.
- La vía está implicada en la patogénesis de la obesidad, NAFLD, NASH, diabetes y aterosclerosis.
- La inhibición de la muesca presenta una vía terapéutica prometedora para las enfermedades metabólicas.
Conclusiones:
- La vía de señalización de Notch contribuye significativamente al desarrollo y la progresión de enfermedades metabólicas.
- Comprender el papel de Notch en la disfunción metabólica es fundamental para desarrollar tratamientos efectivos.
- La señalización de Notch tiene un potencial terapéutico para el manejo de la obesidad y las afecciones metabólicas relacionadas.
Videos de Conceptos Relacionados
03:14Notch Signaling Pathway
4.4K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.4K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Regulation of Metabolism
9.9K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.9K
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K